Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket Finances February 28, 2022 Viatris Inc. VTRS, +4.38%, the corporate fashioned by the merger of Mylan and Pfizer Inc. PFE, +3.83% unit Upjohn in…
Opendoor shares drop despite Q4 results, outlook well above expectations Technology February 24, 2022 Residence gross sales know-how pioneer Opendoor this afternoon reported This autumn income and revenue that each simply topped Wall Road’s…
